This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-146a-5p | ADCY1 | -1.12 | 0.05777 | -0.03 | 0.96543 | mirMAP | -0.39 | 8.0E-5 | NA | |
2 | hsa-miR-146a-5p | CBX5 | -1.12 | 0.05777 | -0.19 | 0.43077 | mirMAP | -0.11 | 0.00031 | NA | |
3 | hsa-miR-146a-5p | CDON | -1.12 | 0.05777 | -0.13 | 0.81496 | mirMAP | -0.17 | 0.01139 | NA | |
4 | hsa-miR-146a-5p | CDS2 | -1.12 | 0.05777 | -0.08 | 0.71807 | mirMAP | -0.1 | 0.00019 | NA | |
5 | hsa-miR-146a-5p | CECR6 | -1.12 | 0.05777 | -0.7 | 0.21209 | mirMAP | -0.19 | 0.0055 | NA | |
6 | hsa-miR-146a-5p | CUEDC1 | -1.12 | 0.05777 | 0.25 | 0.34421 | mirMAP | -0.12 | 0.00022 | NA | |
7 | hsa-miR-146a-5p | CXXC4 | -1.12 | 0.05777 | 0.44 | 0.59138 | MirTarget | -0.34 | 0.00086 | NA | |
8 | hsa-miR-146a-5p | CYB5D1 | -1.12 | 0.05777 | 0.08 | 0.79303 | mirMAP | -0.22 | 0 | NA | |
9 | hsa-miR-146a-5p | DTNA | -1.12 | 0.05777 | -1.15 | 0.08809 | MirTarget | -0.3 | 0.00028 | NA | |
10 | hsa-miR-146a-5p | FOXK1 | -1.12 | 0.05777 | -0.08 | 0.78218 | mirMAP | -0.13 | 0.00026 | NA | |
11 | hsa-miR-146a-5p | FOXP2 | -1.12 | 0.05777 | 0.26 | 0.75107 | mirMAP | -0.31 | 0.00274 | NA | |
12 | hsa-miR-146a-5p | FZD3 | -1.12 | 0.05777 | -0.28 | 0.48833 | MirTarget | -0.2 | 6.0E-5 | NA | |
13 | hsa-miR-146a-5p | GNAO1 | -1.12 | 0.05777 | 0.31 | 0.66625 | mirMAP | -0.35 | 8.0E-5 | NA | |
14 | hsa-miR-146a-5p | GRIA3 | -1.12 | 0.05777 | 0.4 | 0.66415 | MirTarget | -0.38 | 0.00076 | NA | |
15 | hsa-miR-146a-5p | GRSF1 | -1.12 | 0.05777 | 0.37 | 0.06369 | MirTarget; mirMAP | -0.13 | 0 | NA | |
16 | hsa-miR-146a-5p | KCNB1 | -1.12 | 0.05777 | -0.26 | 0.80086 | mirMAP | -0.41 | 0.00161 | NA | |
17 | hsa-miR-146a-5p | KIAA1958 | -1.12 | 0.05777 | 0.34 | 0.45736 | mirMAP | -0.23 | 3.0E-5 | NA | |
18 | hsa-miR-146a-5p | LONRF2 | -1.12 | 0.05777 | 0.28 | 0.70025 | mirMAP | -0.23 | 0.01105 | NA | |
19 | hsa-miR-146a-5p | MTUS2 | -1.12 | 0.05777 | 0.29 | 0.77247 | miRNAWalker2 validate | -0.52 | 3.0E-5 | NA | |
20 | hsa-miR-146a-5p | MXRA7 | -1.12 | 0.05777 | -0.39 | 0.27304 | mirMAP | -0.18 | 4.0E-5 | NA | |
21 | hsa-miR-146a-5p | NECAB1 | -1.12 | 0.05777 | -0.1 | 0.85106 | MirTarget | -0.23 | 0.00102 | NA | |
22 | hsa-miR-146a-5p | NEDD4L | -1.12 | 0.05777 | 0.06 | 0.87644 | mirMAP | -0.11 | 0.01807 | NA | |
23 | hsa-miR-146a-5p | NFASC | -1.12 | 0.05777 | -0.41 | 0.55714 | mirMAP | -0.29 | 0.00095 | 23706078; 23027628; 18504431 | Celastrol induces apoptosis of gastric cancer cells by miR 146a inhibition of NF κB activity;53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF κB through miR 146a;Expression of microRNA 146 suppresses NF kappaB activity with reduction of metastatic potential in breast cancer cells |
24 | hsa-miR-146a-5p | PAIP2B | -1.12 | 0.05777 | -0.12 | 0.86529 | mirMAP | -0.3 | 0.00089 | NA | |
25 | hsa-miR-146a-5p | PALM2 | -1.12 | 0.05777 | 0.42 | 0.36711 | mirMAP | -0.23 | 5.0E-5 | NA | |
26 | hsa-miR-146a-5p | PLXNA2 | -1.12 | 0.05777 | 1.58 | 2.0E-5 | mirMAP | -0.14 | 0.00298 | NA | |
27 | hsa-miR-146a-5p | POLR3H | -1.12 | 0.05777 | -0.03 | 0.90578 | miRNATAP | -0.12 | 4.0E-5 | NA | |
28 | hsa-miR-146a-5p | PRLR | -1.12 | 0.05777 | 1.14 | 0.17196 | mirMAP | -0.51 | 0 | NA | |
29 | hsa-miR-146a-5p | RAB3B | -1.12 | 0.05777 | 2.29 | 0.00176 | mirMAP | -0.28 | 0.00206 | NA | |
30 | hsa-miR-146a-5p | RGP1 | -1.12 | 0.05777 | 0.12 | 0.79841 | mirMAP | -0.14 | 0.01526 | NA | |
31 | hsa-miR-146a-5p | RHOBTB3 | -1.12 | 0.05777 | -0.12 | 0.81971 | MirTarget | -0.15 | 0.01636 | NA | |
32 | hsa-miR-146a-5p | RIMS2 | -1.12 | 0.05777 | 0.87 | 0.43628 | mirMAP | -0.58 | 2.0E-5 | NA | |
33 | hsa-miR-146a-5p | RND2 | -1.12 | 0.05777 | 0.3 | 0.63691 | mirMAP | -0.39 | 0 | NA | |
34 | hsa-miR-146a-5p | SCN3B | -1.12 | 0.05777 | -0.02 | 0.98374 | MirTarget | -0.41 | 5.0E-5 | NA | |
35 | hsa-miR-146a-5p | SLC25A27 | -1.12 | 0.05777 | -0.44 | 0.48871 | MirTarget | -0.17 | 0.03399 | NA | |
36 | hsa-miR-146a-5p | SLC2A13 | -1.12 | 0.05777 | 0.31 | 0.52341 | mirMAP | -0.25 | 2.0E-5 | NA | |
37 | hsa-miR-146a-5p | SMAD4 | -1.12 | 0.05777 | -0.5 | 0.1224 | miRNAWalker2 validate; miRTarBase | -0.12 | 0.00362 | 21982769; 27438138; 22020746 | The results indicated that miR-146a regulated the sensitivity of HCC cells to the cytotoxic effects of IFN-α through SMAD4 suggesting that this miRNA could be suitable for prediction of the clinical response and potential therapeutic target in HCC patients on IFN-based therapy;SMAD4 was identified as a miR-146a target and was downregulated in BARF1-expressing cells whereas SMAD4 expression was restored by anti-miR-146a; Knockdown of BARF1 in YCCEL1 cells upregulated SMAD4 and this effect was reversed by miR-146a overexpression; In stomach cancer tissues miR-146a was expressed at higher levels and more frequent NFκB nuclear positivity immunohistochemically but not of SMAD4 nuclear loss was found in the EBV-positive group compared with the EBV-negative group; In conclusion EBV-encoded BARF1 promotes cell proliferation in stomach cancer by upregulating NFκB and miR-146a and downregulating SMAD4 thereby contributing to EBV-induced stomach cancer progression;Increased miR 146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis; Using target prediction algorithms luciferase reporter assay and Western blot assay SMAD family member 4 SMAD4 was identified as a target gene of miR-146a in gastric cancer; Moreover an inverse correlation was observed between the expression of SMAD4 mRNA and miR-146a in gastric cancer tissues R=-0.731 P=0.039 Pearson's correlation; Taken together our results provide important evidence that miR-146a can directly target SMAD4 and suggest that miR-146a may play a role in the development of gastric cancer by modulating cell proliferation and apoptosis |
38 | hsa-miR-146a-5p | SRR | -1.12 | 0.05777 | -0.45 | 0.14307 | miRNATAP | -0.17 | 0 | NA | |
39 | hsa-miR-146a-5p | TAF9B | -1.12 | 0.05777 | -0.04 | 0.87815 | miRNATAP | -0.15 | 1.0E-5 | NA | |
40 | hsa-miR-146a-5p | TANC2 | -1.12 | 0.05777 | 0.22 | 0.53322 | mirMAP | -0.1 | 0.01786 | NA | |
41 | hsa-miR-146a-5p | TM9SF2 | -1.12 | 0.05777 | 0.36 | 0.17707 | miRNATAP | -0.11 | 0.00063 | NA | |
42 | hsa-miR-146a-5p | TMEM120B | -1.12 | 0.05777 | -0.02 | 0.9519 | MirTarget | -0.1 | 0.00095 | NA | |
43 | hsa-miR-146a-5p | TMEM132B | -1.12 | 0.05777 | 1.09 | 0.13939 | mirMAP | -0.27 | 0.00346 | NA | |
44 | hsa-miR-146a-5p | TMEM209 | -1.12 | 0.05777 | -0.01 | 0.98078 | MirTarget | -0.12 | 0.00018 | NA | |
45 | hsa-miR-146a-5p | TMX4 | -1.12 | 0.05777 | 0.36 | 0.29632 | mirMAP | -0.17 | 6.0E-5 | NA | |
46 | hsa-miR-146a-5p | USP22 | -1.12 | 0.05777 | -0.34 | 0.18967 | mirMAP | -0.11 | 0.00039 | NA | |
47 | hsa-miR-146a-5p | ZBED3 | -1.12 | 0.05777 | -0.3 | 0.56772 | mirMAP | -0.16 | 0.01031 | NA | |
48 | hsa-miR-146a-5p | ZHX3 | -1.12 | 0.05777 | 0.08 | 0.80185 | mirMAP | -0.18 | 0 | NA | |
49 | hsa-miR-146a-5p | ZNF10 | -1.12 | 0.05777 | -0.24 | 0.51276 | MirTarget | -0.16 | 0.00046 | NA | |
50 | hsa-miR-146a-5p | ZNF618 | -1.12 | 0.05777 | -0.36 | 0.29567 | mirMAP | -0.2 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Wnt_signaling_pathway_hsa04310 | 3 | 146 | 0.005813 | 0.3023 | |
2 | Apelin_signaling_pathway_hsa04371 | 2 | 137 | 0.04608 | 0.7377 | |
3 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 2 | 139 | 0.04729 | 0.7377 | |
4 | Hippo_signaling_pathway_hsa04390 | 2 | 154 | 0.05675 | 0.7377 | |
5 | cAMP_signaling_pathway_hsa04024 | 2 | 198 | 0.08773 | 0.8131 | |
6 | Rap1_signaling_pathway_hsa04015 | 2 | 206 | 0.09382 | 0.8131 | |
7 | Neuroactive_ligand_receptor_interaction_hsa04080 | 2 | 278 | 0.1532 | 0.8611 |